NYSE:SQZ
SQZ Biotechnologies Company
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.sqzbiotech.comipo date
Oct 30, 2020
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus